000 01348 a2200325 4500
005 20250516163706.0
264 0 _c20140318
008 201403s 0 0 eng d
022 _a1478-3231
024 7 _a10.1111/liv.12213
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHuang, Yi-Hsiang
245 0 0 _aThe role of mTOR inhibitors in the treatment of hepatocellular carcinoma.
_h[electronic resource]
260 _bLiver international : official journal of the International Association for the Study of the Liver
_cSep 2013
300 _a1133-4 p.
_bdigital
500 _aPublication Type: Editorial; Comment
650 0 4 _aAminopyridines
_xpharmacology
650 0 4 _aCarcinoma, Hepatocellular
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aImidazoles
_xpharmacology
650 0 4 _aLiver Neoplasms
_xdrug therapy
650 0 4 _aMorpholines
_xpharmacology
650 0 4 _aPhosphoinositide-3 Kinase Inhibitors
650 0 4 _aQuinolines
_xpharmacology
650 0 4 _aSirolimus
_xanalogs & derivatives
650 0 4 _aTOR Serine-Threonine Kinases
_xantagonists & inhibitors
700 1 _aLin, Han-Chieh
773 0 _tLiver international : official journal of the International Association for the Study of the Liver
_gvol. 33
_gno. 8
_gp. 1133-4
856 4 0 _uhttps://doi.org/10.1111/liv.12213
_zAvailable from publisher's website
999 _c22991113
_d22991113